These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [USE IN CARDIOLOGY OF A NEW ANTICOAGULANT: DICOUMOXYL (1-BIS-METHOXY (4-HYDROXY, 3-COUMARINYL) 2,2-ETHANE). APROPOS OF 29 CASES]. MERIEL P; GALINIER F; BOUNHOURE JP; GAVALDA J Toulouse Med; 1964; 65():849-58. PubMed ID: 14204295 [No Abstract] [Full Text] [Related]
27. [COAGULATION AND ANTICOAGULATION SYSTEM OF THE BLOOD AND ITS REACTION TO CORONARY CIRCULATION DISORDERS]. IAROSHEVSKII AIa; ZHAVORONKOVA EK Ter Arkh; 1964 Jan; 36():36-42. PubMed ID: 14149441 [No Abstract] [Full Text] [Related]
28. [EVALUATION OF THE ANTICOAGULANT TREATMENT OF MYOCARDIAL INFARCTION]. MOJKOWSKA H Pol Tyg Lek; 1964 Sep; 19():1495-8. PubMed ID: 14250261 [No Abstract] [Full Text] [Related]
29. THE ROLE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION. LEAK D Geriatrics; 1965 Feb; 20():150-5. PubMed ID: 14256116 [No Abstract] [Full Text] [Related]
30. ANTICOAGULANTS IN MYOCARDIAL INFARCTION. MCDONALD GL Bull Postgrad Comm Med Univ Syd; 1963 Dec; 19():226-30. PubMed ID: 14089498 [No Abstract] [Full Text] [Related]
31. OUTPATIENT ANTICOAGULATION: A PROBLEM IN LONG-TERM MANAGEMENT. BEINSTEIN J Va Med Mon (1918); 1964 Apr; 91():149-54. PubMed ID: 14140408 [No Abstract] [Full Text] [Related]
32. CLINICAL MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION. HURLBURT FW; GILLIS JG; KAVANAGH-GRAY D; PALMER RA; SHALLARD B; TRAYNOR JA Can Med Assoc J; 1965 Aug; 93(9):398-403. PubMed ID: 14339304 [TBL] [Abstract][Full Text] [Related]
33. [CLINICAL AND PROGNOSTIC DATA AND THERAPEUTIC ASPECTS OF ACUTE MYOCARDIAL INFARCT]. VISANI A Clin Ter; 1964 Oct; 31():3-41. PubMed ID: 14225012 [No Abstract] [Full Text] [Related]
34. [CLINICAL EXPERIMENTATION WITH A NEW SYNTHETIC ANTICOAGULANT, A COUMARIN DERIVATIVE: 1-METHOXY-2, 2-BIS (4-HYDROXY-3-COUMARINYL)-ETHANE]. HUTINEL P Lyon Med; 1964 Jun; 211():1569-604. PubMed ID: 14161671 [No Abstract] [Full Text] [Related]
35. USE OF ANTICOAGULANTS IN TREATMENT OF MYOCARDIAL INFARCTION. CORDAY E; MITCHELL EB; OWREN PA; ROSENBERG BA Dis Chest; 1964 Mar; 45():225-35. PubMed ID: 14132267 [No Abstract] [Full Text] [Related]
36. OFFICE MANAGEMENT OF THE ANTICOAGULATED PATIENT. UDALL JA Geriatrics; 1964 Jul; 19():505-10. PubMed ID: 14183246 [No Abstract] [Full Text] [Related]
37. LOW-DENSITY SERUM LIPOPROTEINS IN SURVIVORS AND NONSURVIVORS OF MYOCARDIAL INFARCTION. KRASNO LR; KIDERA GJ; LACK AR; JOHNSON HP; NATHANSON L Postgrad Med; 1964 Dec; 36():602-7. PubMed ID: 14234320 [No Abstract] [Full Text] [Related]
38. PHENPROCOUMON AND HEPARIN AFTER MYOCARDIAL INFARCTION. A 12-MONTH COMPARISON. LOVELL RR; DENBOROUGH MA; NESTEL PJ; GOBLE AJ Arch Intern Med; 1964 Feb; 113():267-74. PubMed ID: 14090396 [No Abstract] [Full Text] [Related]
39. CLINICAL FEATURE OF MYOCARDIAL INFARCTION IN JAPAN. YOSHITOSHI Y; HANAOKA W; NAGASAKA M; MIYASHITA H; YAMAGUCHI A; ITO T; WATANABE S; OSHIMA M; SHINOHARA Y Jpn Heart J; 1964 Nov; 5():497-511. PubMed ID: 14250894 [No Abstract] [Full Text] [Related]
40. ANTICOAGULANTS IN ACUTE MYOCARDIAL INFARCTION. RECURENT MYOCARDIAL INFARCTION AND DEATH AFTER DISCONTINUANCE OF ANTICOAGULANT THERAPY. SIVERTISSEN E; LYGREN T; HANGAARD G; ALVSAKER JO Acta Med Scand; 1963 Aug; 174():179-82. PubMed ID: 14051134 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]